Microbicides: latest news

Microbicides resources

  • Microbicides

    Microbicides are any substances which protect people against infection by microbes, such as viruses or bacteria, on contact with those microbes....

    From: Preventing HIV

    Information level Level 4
  • Microbicides

    A microbicide is a topical agent that, when applied to a mucosal surface, serves as a barrier to infection. Microbicides can come in the form of...

    From: HIV transmission & testing

    Information level Level 4

Microbicides features

Microbicides news from aidsmap

More news

Microbicides news selected from other sources

  • HIV-fighting intravaginal ring research nets $20M from NIH

    The U.S. National Institutes of Health devoted $20 million to a group of institutions including Miriam Hospital in Rhode Island to develop an HIV drug-delivering intravaginal ring. The design of a successful ring is a priority in HIV research, and the sustained release of drugs the ring offers could eventually play a crucial role in HIV prevention in the developing world.

    15 September 2014 | Fierce Drug Delivery
  • Semi-soft vaginal drug-delivery suppository could limit spread of HIV, AIDS

    A unique method for delivering compounds that could positively impact the global battle against HIV and AIDS may be possible, thanks to researchers in Penn State's College of Agricultural Sciences. A semi-soft vaginal suppository made from the seaweed-derived food ingredient carrageenan and loaded with the antiviral drug Tenofovir provides a woman-initiated, drug-delivery vehicle that can protect against the spread of sexually transmitted infections during unprotected heterosexual intercourse, the researchers said.

    02 September 2014 | Medical News Today
  • Weaving HIV protection: UW researchers use fabric to protect women against infection

    Scientists use a method of weaving the drug into silk-like fibers that dissolve quickly when inserted into the vagina before sex, delivering a higher dose than is possible with other topical methods currently being tested.

    05 August 2014 | Business Journal
  • ASPIRE Phase III trial of a vaginal ring for HIV prevention completes enrollment of 2,629 women

    MTN’s trial testing dapivirine ring on track to finish next year; IPM’s sister Phase III trial ongoing.

    30 June 2014 | Microbicide Trials Network
  • Rectal tenofovir gel yields much higher rectal and vaginal levels than oral tenofovir

    Tenofovir 1% gel applied rectally yielded rectal tissue concentrations orders of magnitude greater than those achieved with oral tenofovir, according to results of an 18-person study by US researchers. Systemic tenofovir exposure was lower with 1% gel than with oral tenofovir, but vaginal exposure was greater with the rectal gel.

    02 June 2014 | NATAP
  • IPM Receives Worldwide Rights to HIV Prevention Medicines

    The International Partnership for Microbicides (IPM) announced today that it has received exclusive worldwide rights to a promising HIV prevention medicine called dapivirine from Janssen R&D Ireland, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

    09 May 2014 | International Partnership for Microbicides
  • Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum

    Population Council scientists and their partners have found that their proprietary microbicide gel is safe, stable, and can prevent the transmission of multiple sexually transmitted infections in both the vagina and rectum in animals: HIV, herpes simplex virus 2, and human papillomavirus.

    22 April 2014 | Eurekalert Medicine & Health
  • Study: In two-drug, HIV-preventing vaginal ring, only one drug does the job

    The National Institutes of Health has shown that a study of its vaginal ring for the prevention of HIV came back with mixed results. The ring, which delivers two drugs, was safe for 28 days, but only one of the antiretroviral drugs was effective in protecting against the virus.

    10 March 2014 | Fierce Drug Delivery
  • New Rings, Gels, and Films Show Promise in Microbicide Trials

    Experimental vaginal microbicides—products such as gels, films, or flexible rings worn inside the vagina—were the focus of two studies reported Tuesday at the 21st Conference on Retroviruses and Opportunistic Infections.

    05 March 2014 | BETA blog
  • Study comparing injectable contraceptives DMPA and NET-EN finds HIV risk higher with DMPA

    Women who used an injectable contraceptive called DMPA were more likely to acquire HIV than women using a similar product called NET-EN, according to a secondary analysis of data from a large HIV prevention trial called VOICE. The new analysis, conducted by researchers from the NIH-funded Microbicide Trials Network, is the first head-to-head observational study to directly compare differences in HIV risk between users of DMPA and NET-EN.

    04 March 2014 | Eurekalert Medicine & Health
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.